Dipeptidyl Peptidase-4 Inhibitors for the Potential Treatment of Brain Disorders; A Mini-Review With Special Focus on Linagliptin and Stroke

by Vladimer Darsalia, Odd Erik Johansen, Grazyna Lietzau, Thomas Nyström, Thomas Klein, Cesare Patrone
Published 2019-05-01

Differences in glycemic control between the treatment arms in cardiovascular outcome trials of type 2 diabetes medications do not explain cardiovascular benefits

by Darren K. McGuire, Silvio E. Inzucchi, Odd Erik Johansen, Julio Rosenstock, Jyothis T. George, Nikolaus Marx
Published 2021-12-01

Asymptomatic coronary artery disease in a Norwegian cohort with type 2 diabetes: a prospective angiographic study with intravascular ultrasound evaluation

by Satish Arora, Anne Pernille Ofstad, Geir R. Ulimoen, Kåre I. Birkeland, Knut Endresen, Lars Gullestad, Odd Erik Johansen
Published 2019-03-01

Oral enzyme combination with bromelain, trypsin and the flavonoid rutoside reduces systemic inflammation and pain when used pre- and post-operatively in elective total hip replacem...

by Jiří Vosáhlo, Adam Salus, Michael Smolko, Barbora Němcová, Veit Nordmeyer, Milos Mikles, Stefanie M. Rau, Odd Erik Johansen
Published 2023-07-01

Development of a tool to predict the risk of incident heart failure in a general population: the HUNT for HF risk score

by Anne Pernille Ofstad, Cathrine Brunborg, Odd Erik Johansen, Bjørn Mørkedal, Morten W. Fagerland, Lars Erik Laugsand, Lars L. Gullestad, Håvard Dalen
Published 2023-10-01

Rationale and design of the CAROLINA® - cognition substudy: a randomised controlled trial on cognitive outcomes of linagliptin versus glimepiride in patients with type 2 diabetes m...

by Geert Jan Biessels, Jolien Janssen, Esther van den Berg, Bernard Zinman, Mark A. Espeland, Michaela Mattheus, Odd Erik Johansen, on behalf of the CAROLINA® investigators
Published 2018-01-01

ILD-specific health-related quality of life in systemic sclerosis-associated ILD compared with IPF

by Surinder S Birring, May Brit Lund, Michael T Durheim, Tomas M Eagan, Arnt-Ove Hovden, Gisle Bjerke, Trygve M Jonassen, Odd Erik Johansen, Tone Sjåheim
Published 2020-05-01

Oligomalt, a New Slowly Digestible Carbohydrate, Is Well Tolerated in Healthy Young Men and Women at Intakes Up to 180 Gram per Day: A Randomized, Double-Blind, Crossover Trial

by Odd Erik Johansen, Delphine Curti, Maximilian von Eynatten, Andreas Rytz, Anirban Lahiry, Frederik Delodder, Gerhard Ufheil, Carmine D’Urzo, Audrey Orengo, Kate Thorne, Jaclyn S. Lerea-Antes
Published 2023-06-01

Diurnal Glycemic Patterns during an 8-Week Open-Label Proof-of-Concept Trial of Empagliflozin in Type 1 Diabetes.

by Bruce A Perkins, David Z I Cherney, Nima Soleymanlou, Justin A Lee, Helen Partridge, Holly Tschirhart, Bernard Zinman, Roger Mazze, Nora Fagan, Stefan Kaspers, Hans-Juergen Woerle, Uli C Broedl, Odd Erik Johansen
Published 2015-01-01